
Source externe
Medical Xpress – Actualités Santé
High blood sugar powers an experimental implant that helps improve glucose control in diabetes
High blood sugar, a major problem in type 2 diabetes, could become part of the solution in monitoring the disease. Researchers have developed an experimental implant called NeuroAxis that utilizes a glucose fuel cell to harvest energy and sense metabolic fluctuations in real…
il y a 9 h· Endocrinologie-DiabétologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
World-first study identifies genetic markers of young-onset type 2 diabetes in Chinese population
The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) has conducted the world's first and largest genetic association study of age at diagnosis of type 2 diabetes in a Chinese population. The study identified three genetic regions associated with younger…
il y a 11 h· Endocrinologie-DiabétologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Anti-inflammatory peptide shows potential to prevent diabetes-related vision loss
According to a study published in October in the journal Biomedicine & Pharmacotherapy, a molecule naturally produced by the human body may help protect vision against damage caused by high blood sugar. This finding paves the way for new strategies to prevent diabetic…
hier· Endocrinologie-DiabétologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Common type 1 diabetes score misses over half of partial remissions in youth with overweight or obesity
A Baylor College of Medicine–led team is raising awareness about applying the widely used values of insulin dose-adjusted hemoglobin A1c (IDAA1c) when screening for partial type 1 diabetes remission in youth with overweight or obesity. The study appeared in Diabetes Care.
hier· Endocrinologie-DiabétologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Discovery points to new approach for treating diabetes—no insulin required
Researchers at the University of Cincinnati College of Medicine have identified a previously unknown way the body's muscles absorb glucose from the blood—without insulin.
hier· Endocrinologie-DiabétologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Type 1 and type 2 diabetes therapies show great promise—but treatment is only effective if people can access it
In 2026, over 830 million people worldwide are estimated to live with diabetes—more than ever before.
hier· Endocrinologie-DiabétologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Traffic noise linked to increased risk of type 2 diabetes
Long-term exposure to noise from road traffic and trains is linked to an increased risk of type 2 diabetes, even at relatively low noise levels. This is shown in a large Scandinavian study involving researchers at the Institute of Environmental Medicine (IMM) at Karolinska…
hier· Endocrinologie-DiabétologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
New pill combo approved for breast cancer that stops responding to hormone therapy
People with advanced breast cancer that has stopped responding to hormone therapy now have a new pill-based treatment option.
il y a 3 jours· Endocrinologie-DiabétologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
People with diabetes demand greater control over health data in new digital rights charter
A new international Diabetes Data Rights Charter is calling for people with diabetes to have far greater control over the health data generated by 24/7 diabetes monitoring devices.
il y a 3 jours· Endocrinologie-DiabétologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Q&A: Can the body's natural signals help wounds heal better with diabetes?
Type 1 diabetes, an autoimmune condition in which the pancreas doesn't produce enough insulin, can make it harder for wounds to heal. Researchers are exploring why and how the body's natural healing processes could be improved. Pedro Geralde, PD, a professor at the Université de…
il y a 4 jours· Endocrinologie-DiabétologieLire chez la source
Source externe
OMS – Actualités (Arabe)
المنظمة تصدر أولى مبادئها التوجيهية بشأن داء السكري من النمط 1 لدى البالغين
بعد مرور أكثر من 100 عام على اكتشاف الأنسولين، لا يزال الكثير من الأشخاص المتعايشين مع داء السكري من النمط 1 لا يستطيعون الحصول على الأنسولين ولا على خدمات الرعاية اللازمة لإبقائهم على قيد الحياة. وإن داء السكري من النمط 1 هو حالة مرضية تلازم المُصاب بها طوال العمر ويعجز فيها…
il y a 6 jours· Endocrinologie-DiabétologieLire chez la source
Source externe
OMS – Actualités (Français)
L’OMS publie les premières lignes directrices sur le diabète de type 1 chez l’adulte
Plus de 100 ans après la découverte de l’insuline, de nombreuses personnes atteintes de diabète de type 1 ne peuvent toujours pas avoir accès à l’insuline et aux soins dont elles ont besoin pour survivre. Le diabète de type 1 est une affection à vie dans laquelle le corps ne…
il y a 6 jours· Endocrinologie-DiabétologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Researchers trial AI coach for diabetes
For many people with type 2 diabetes, the challenge isn't understanding what they need to do to stay well. It's doing it consistently. Managing the condition often requires a long-term commitment to healthier eating patterns, regular exercise and medication. But unlike some…
il y a 6 jours· Endocrinologie-DiabétologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
New guidance outlines use of first immunotherapy for children newly diagnosed with type 1 diabetes
For the first time, children ages 8 to 17 who are newly diagnosed with type 1 diabetes have access to an approved treatment that targets the underlying autoimmune disease, rather than solely managing blood sugar levels with insulin.
le 12 nov. 2026· Endocrinologie-DiabétologieLire chez la source
Source externe
The BMJ – Actualités & Recherches
Effect of intensive blood pressure control on cognitive outcomes and brain structures in adults with type 2 diabetes: prespecified analysis of secondary outcomes of BPROAD randomised controlled trial
AbstractObjectiveTo evaluate the effect of intensive compared with standard treatment of systolic blood pressure (SBP) on cognitive outcomes and brain structures in adults with type 2 diabetes.DesignMulticentre, open label, outcome assessor masked, randomised controlled…
le 12 nov. 2026· Endocrinologie-DiabétologieLire chez la source

Source externe
Medical Xpress – Actualités Santé
Research reveals Alzheimer's risk 53% higher for those with type 2 diabetes
A Curtin University-led review has revealed type 2 diabetes significantly raises the risk of developing Alzheimer's disease.
le 12 nov. 2026· Endocrinologie-DiabétologieLire chez la source
Source externe
Medical Xpress – Actualités Santé
Study finds that genetic risk does not explain the maternal effect in type 1 diabetes
Children whose mothers have type 1 diabetes develop the disease at about half the rate of children whose fathers have it. Inherited genetic risk alone does not explain this long-observed maternal effect, according to a study led by researchers at the University of Colorado…
le 10 nov. 2026· Endocrinologie-DiabétologieLire chez la source
Source externe
Medical Xpress – Actualités Santé
Stopping Ozempic may be bad for your health
In people with type 2 diabetes (T2D) and no established cardiovascular disease (CVD), starting glucagon-like peptide-1 receptor agonist (GLP-1) treatment and then stopping is associated with twice the combined risk of heart attack, stroke or death compared with staying on…
le 10 nov. 2026· Endocrinologie-DiabétologieLire chez la source
Page 1 sur 2
Plus anciennes →